- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 146.17M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $545.83M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $574.52M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.57M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.66M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $153.24M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $138.84M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $157.87M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $153.03M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $434.89M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $417.4M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $785.47M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $775.71M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 140.98M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $31.31M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$38.44M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $37.55M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $78.12M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.34 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.34 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $113.61M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$48.5M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$43.34M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $97.35M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $41.13M |